MoneyWorks4Me

Auro Laboratories - Quaterly Results

06 Feb 2026 Evaluate
The total revenue for the December 2025 quarter zoomed 207.46% to Rs. 93.93 millions as compared to Rs. 30.55 millions during the year-ago period.The company almost doubled its revenue to Rs. 19.50 millions  from Rs. 0.51 millions in the quarter ended December 2025.OP of the company witnessed a marginal growth to 42.42 millions from 5.84 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 93.93 30.55 207.46 210.04 118.76 76.86 193.98 536.35 -63.83
Other Income 1.77 1.41 25.53 15.69 6.52 140.64 6.56 15.04 -56.38
PBIDT 42.42 5.84 626.37 80.25 31.41 155.49 40.59 121.74 -66.66
Interest 15.23 2.46 519.11 27.66 7.78 255.53 10.82 7.36 47.01
PBDT 27.19 3.38 704.44 52.59 23.63 122.56 29.77 114.38 -73.97
Depreciation 9.82 2.70 263.70 19.07 8.10 135.43 10.96 10.92 0.37
PBT 17.37 0.68 2454.41 33.52 15.53 115.84 18.81 103.46 -81.82
TAX -2.13 0.17 -1352.94 7.91 3.90 102.82 0.42 25.54 -98.36
Deferred Tax -2.13 0.00 0.00 7.91 0.00 0.00 -0.61 -1.87 -67.38
PAT 19.50 0.51 3723.53 25.61 11.63 120.21 18.39 77.92 -76.40
Equity 62.32 62.32 0.00 62.32 62.32 0.00 62.32 62.32 0.00
PBIDTM(%) 45.16 19.12 136.25 38.21 26.45 44.46 20.92 22.70 -7.81
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..